Log in

Relevant bibliographies by topics / Beta agonists

Contents

Journal articles
Dissertations / Theses
Books
Book chapters
Conference papers
Reports

Academic literature on the topic 'Beta agonists'

Author: Grafiati

Published: 4 June 2021

Last updated: 26 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Beta agonists.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Beta agonists"

1

Kelly, H. William, and Shirley Murphy. "Beta-Adrenergic Agonists for Acute, Severe Asthma." Annals of Pharmacotherapy 26, no. 1 (1992): 81–91. http://dx.doi.org/10.1177/106002809202600115.

Full text

Abstract:

OBJECTIVE: To critically review the use of beta-adrenergic agonists in acute, severe asthma with particular focus on aerosol administration. DATA SOURCES: English language articles published since 1971 on the use of beta-agonists for acute asthma. Studies were identified from bibliographies of book chapters, review articles, and other research articles. STUDY SELECTION: All studies (21 total) comparing systemic with inhaled beta-agonists were reviewed, regardless of their design or outcome. Selected studies highlighting specific aspects of beta-agonist use in acute asthma such as beta-agonists

APA, Harvard, Vancouver, ISO, and other styles

2

&NA;. "Beta agonists." Reactions Weekly &NA;, no. 578 (1995): 5. http://dx.doi.org/10.2165/00128415-199505780-00013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

&NA;. "Beta agonists." Reactions Weekly &NA;, no. 430 (1992): 6. http://dx.doi.org/10.2165/00128415-199204300-00023.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

&NA;. "Beta agonists." Reactions Weekly &NA;, no. 414 (1992): 5. http://dx.doi.org/10.2165/00128415-199204140-00012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

&NA;. "Beta agonists." Reactions Weekly &NA;, no. 312 (1990): 4. http://dx.doi.org/10.2165/00128415-199003120-00012.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

&NA;. "Beta agonists." Reactions Weekly &NA;, no. 487 (1994): 5. http://dx.doi.org/10.2165/00128415-199404870-00017.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

&NA;. "Beta agonists." Reactions Weekly &NA;, no. 500 (1994): 5. http://dx.doi.org/10.2165/00128415-199405000-00014.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Mio, T., Y. Adachi, S. Carnevali, D. J. Romberger, J. R. Spurzem, and S. I. Rennard. "Beta-adrenergic agonists attenuate fibroblast-mediated contraction of released collagen gels." American Journal of Physiology-Lung Cellular and Molecular Physiology 270, no. 5 (1996): L829—L835. http://dx.doi.org/10.1152/ajplung.1996.270.5.l829.

Full text

Abstract:

The effects of beta-adrenergic agonists on fibroblast-mediated collagen gel contraction were investigated. beta-Agonists isoproterenol and epinephrine significantly attenuated fibroblast-mediated gel contraction in a concentration-dependent manner, whereas alpha-agonist norepinephrine had no effect. The biologically active form of isoproterenol, (-)-isoproterenol, was 10-fold more effective than the optical isoform, (+)-isoproterenol. beta-Antagonists sotalol and propranolol reversed the attenuation caused by 10(-7) M isoproterenol or epinephrine at the concentration of 10(-7) M or 10(-6) M, b

APA, Harvard, Vancouver, ISO, and other styles

9

Oscanoa, T. J. "Seguridad de los beta 2 agonistas (?2a) en asma bronquial." Revista de la Facultad de Ciencias Médicas de Córdoba 71, no. 1 (2014): 43–53. http://dx.doi.org/10.31053/1853.0605.v71.n1.8426.

Full text

Abstract:

ResumenLos broncodilatadores beta 2 agonistas (?2A) forman parte muy importante en el farmacoterapia del asma bronquial, una enfermedad que avanza en el mundo de manera epidémica. Los ?2A son prescritos a millones de personas en el mundo, por consiguiente los aspectos de seguridad son de interés público. Los broncodilatadores ?2A de acción corta (Short-Acting ?2 Agonists o SABA) como salbutamol inhalatorio, según las evidencias actuales, confirman su seguridad en su uso como fármaco de rescate o a demanda. Los broncodilatadores ?2A de acción prolongada (Long-Acting ?2 Agonists o LABA) se utili

APA, Harvard, Vancouver, ISO, and other styles

10

Feldman, R. D., G. W. Hunninghake, and W. L. McArdle. "Beta-adrenergic-receptor-mediated suppression of interleukin 2 receptors in human lymphocytes." Journal of Immunology 139, no. 10 (1987): 3355–59. http://dx.doi.org/10.4049/jimmunol.139.10.3355.

Full text

Abstract:

Abstract Adrenergic receptor agonists are known to attenuate the proliferative response of human lymphocytes after activation; however, their mechanism of action is unknown. Since expression of interleukin 2 (IL-2) receptors is a prerequisite for proliferation, the effect of beta-adrenergic receptor agonists on lymphocyte IL-2 receptors was studied on both mitogen-stimulated lymphocytes and IL-2-dependent T lymphocyte cell lines. In both cell types the beta-adrenergic receptor agonist isoproterenol blocked the expression of IL-2 receptors, as determined with the IL-2 receptor anti-TAC antibody

APA, Harvard, Vancouver, ISO, and other styles

More sources

Dissertations / Theses on the topic "Beta agonists"

1

Elliott, Christopher T. "Detection, pharmacokinetics and molecular mimicry of beta agonists." Thesis, Queen's University Belfast, 1996. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.247342.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Sweet, Andrew. "#beta#-adrenergic agonists and lean deposition in animals." Thesis, University of Nottingham, 1991. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.292616.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Koch, Sarah. "Pharmacogenetics of inhaled beta-2-agonists and athletic performance." Thesis, University of British Columbia, 2011. http://hdl.handle.net/2429/37901.

Full text

Abstract:

The A46G single nucleotide polymorphism (SNP) and the C79G SNP of the adrenergic β2-receptor gene (ADRB2) are associated with the regulation of cardiorespiratory responses, to the inhalation of salbutamol, such as bronchodilation, heart rate and ventilation. PURPOSE: To determine (1) the effect of susceptibility to exercise-induced bronchoconstriction (EIB) and (2) the effect of genetic variation at the ADRB2 A46G and the C79G SNPs on athletic performance after the inhalation of salbutamol. METHODS: Genetic variation for the A46G SNP (AA: 4; AG: 15; GG: 21; unidentified: 2) and the C79G SNP

APA, Harvard, Vancouver, ISO, and other styles

4

Thompson-Coon, J. "Clinical studies on interactions between #beta#-agonists and glucocorticoids." Thesis, University of Nottingham, 1998. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.285776.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Gill, Hardyal S. "Soft [beta]-adrenoceptor agonists for topical use in psoriasis." Thesis, Aston University, 1994. http://publications.aston.ac.uk/11053/.

Full text

Abstract:

Psoriasis is characterised by epidermal proliferation and inflammation resulting in the appearance of elevated erythematous plaques. The ratio of c~AMP/c~GMP is decreased in psoriatic skin and when the epidermal cell surface receptors are stimulated by β-adrenergic agonists, intracellular ATP is transformed into c-AMP, thus restoring the c~AMP/c~GMP levels. This thesis describes a series of β-adrenoceptor agonists for topical delivery based upon the soft-drug approach. Soft drugs are defined as biologically active, therapeutically useful chemical compounds (drugs) characterised by a predictabl

APA, Harvard, Vancouver, ISO, and other styles

6

Twentyman, Orion Peter. "Mechanisms of allergen-induced late phase asthmatic responses and increased bronchial responsiveness." Thesis, University of Southampton, 1992. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.296053.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Van, Patrick P. T. "Comparison of nebulised vs MDI-spacer delivered beta-2 agonist therapy in patients with asthma in the community." Thesis, The University of Sydney, 2001. https://hdl.handle.net/2123/27750.

Full text

Abstract:

Objective: The aim of this study was to determine whether asthma symptoms and beta-2 agonist usage were any different between community patients using a nebuliser or a metereddose inhaler with a spacer (MDI—spacer) to deliver beta-2 agonist for the relief of symptoms. Design and setting: A randomised intervention versus control group study in a community pharmacy. Participants: 48 patients with asthma over 2 years of age; 34 completed the study. Intervention: Subjects with a repeat prescription for salbutamol nebules were randomised to switch to MDI—spacer with patient counselling and

APA, Harvard, Vancouver, ISO, and other styles

8

Clausen, Lisa. "Effects of beta-2 adrenergic receptor agonists in DOK7 congenital myasthenic syndrome." Thesis, University of Oxford, 2015. https://ora.ox.ac.uk/objects/uuid:9360c51b-8497-47ca-bd16-e917a3614a25.

Full text

Abstract:

Congenital myasthenic syndromes (CMS) are a rare group of heterogeneous disorders, characterised by compromised neuromuscular transmission and symptoms of fatiguable muscle weakness. CMS is caused by mutations in genes that affect the structure and function of the neuromuscular junction (NMJ). In about 20% of CMS cases, patients have mutations in the gene DOK7; the protein product, DOK7, is crucial for maintaining the dense aggregation of acetylcholine receptor (AChR) clusters at the NMJ. DOK7-CMS patients do not respond to treatment with acetylcholinesterase inhibitors which are the first lin

APA, Harvard, Vancouver, ISO, and other styles

9

Vathenen, Arumugam Santhire. "The effect of beta agonists and corticosteroids on bronchial reactivity in asthma." Thesis, University of Southampton, 1989. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.278555.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Salie, Ruduwaan. "The mechanism of pharmacological preconditioning of rat myocardium with beta-adrenergic agonists." Thesis, Stellenbosch : University of Stellenbosch, 2011. http://hdl.handle.net/10019.1/6630.

Full text

Abstract:

Thesis (PhD)--University of Stellenbosch, 2011.<br>ENGLISH ABSTRACT: The Mechanism of -adrenergic preconditioning ( -PC) Ischaemic preconditioning (IPC), a potent endogenous protective intervention against myocardial ischaemia, is induced by exposure of the heart to repetitive short episodes of ischaemia and reperfusion. The protective effects of this phenomenon have been demonstrated to be mediated by release of autocoids such as adenosine, opioids and bradykinin. Release of endogenous catecholamines and activation of the beta-adrenergic receptors (b-AR) have also been shown to be invo

APA, Harvard, Vancouver, ISO, and other styles

More sources

Books on the topic "Beta agonists"

1

Romain, Pauwels, and O'Byrne Paul M. 1951-, eds. Beta₂-agonists in asthma treatment. Dekker, 1997.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

2

Grassitelli, A. Impiego di beta agonisti in alimentazione animale. Istituto superiore di sanità, 1989.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

3

P, Hanrahan J., and Commission of the European Communities. Coordination of Agricultural Research., eds. Beta-agonists and their effects on animal growth and carcass quality: A seminar in the CEC Programme of Coordination of Research in Animal Husbandry, held in Brussels, 19-20 May 1987. Elsevier Applied Science, 1987.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

4

Friedrich, Kummer, and Vienna Asthma Forum (6th : 1996), eds. Treatment of asthma: The long-acting beta-2-agonists. Springer-Verlag, 1998.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

5

Dr, Johnson Malcolm, Small Roger, British Pharmacological Society Meeting, and Glaxo Group Research Limited, eds. [Beta]-adrenoceptor agonists and the airways: Held as satellite meeting to the British Pharmacological Society Meeting, School of Biological Sciences, University of Manchester, 12-15 April 1994. Royal Society of Medicine Press, 1995.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

6

Akhlaghi, Shirin. The metabolic effects of beta-agonists and antagonists: Focus on beta-1 selectivity. University of Birmingham, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

7

1944-, Costello J. F., and Mann Ronald D. 1928-, eds. Beta agonists in the treatment of asthma: The proceedings. Parthenon Pub. Group, 1992.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

8

Kummer, Friedrich, ed. Treatment of Asthma: The long-acting beta-2-agonists. Springer Vienna, 1998. http://dx.doi.org/10.1007/978-3-7091-7513-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Gill, Hardyal Singh. Soft [beta]-adrenoceptor agonists for topical use in psoriasis. Aston University. Department of Pharmaceutical and Biological Sciences, 1994.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

10

D, Strosberg A., ed. The B₃-adrenoreceptor. Taylor & Francis, 2000.

Find full text

APA, Harvard, Vancouver, ISO, and other styles

More sources

Book chapters on the topic "Beta agonists"

1

Ballard, Philip L. "Beta-Adrenergic Agonists." In Hormones and Lung Maturation. Springer Berlin Heidelberg, 1986. http://dx.doi.org/10.1007/978-3-642-82483-8_8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Chester, Neil, and David R. Mottram. "Beta-2 agonists." In Drugs in Sport. Routledge, 2018. http://dx.doi.org/10.4324/9781315222790-11.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Chester, Neil, and David Mottram. "Beta-2 agonists." In Drugs in Sport, 8th ed. Routledge, 2021. http://dx.doi.org/10.4324/9781003096160-12.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Hill, Keith, Tom Baranowski, Walter Schmidt, et al. "Beta 2-Adrenoceptor Agonists." In Encyclopedia of Exercise Medicine in Health and Disease. Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-540-29807-6_2141.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Handley, D. A., J. Morley, and H. S. Nelson. "Single-Isomer β-Agonists." In New Drugs for Asthma, Allergy and COPD. KARGER, 2001. http://dx.doi.org/10.1159/000062133.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Johnson, Malcolm, and Gerry W. E. Hagan. "Long-Acting β₂-Agonists." In New Drugs for Asthma, Allergy and COPD. KARGER, 2001. http://dx.doi.org/10.1159/000062130.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Villiger, Beat. "Long-acting beta-agonists in exercise induced asthma." In Treatment of Asthma: The long-acting beta-2-agonists. Springer Vienna, 1998. http://dx.doi.org/10.1007/978-3-7091-7513-2_7.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Adcock, Ian M., and D. A. Stevens. "Molecular interactions between glucocorticoids and β2-agonists." In Treatment of Asthma: The long-acting beta-2-agonists. Springer Vienna, 1998. http://dx.doi.org/10.1007/978-3-7091-7513-2_2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Hershberger, Ray E. "Beta-Adrenergic Receptor Agonists and Antagonists in Heart Failure." In Congestive Heart Failure. Springer New York, 1994. http://dx.doi.org/10.1007/978-1-4613-8315-4_25.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Michel, Lauriane Y. M., and Jean-Luc Balligand. "New and Emerging Therapies and Targets: Beta-3 Agonists." In Heart Failure. Springer International Publishing, 2016. http://dx.doi.org/10.1007/164_2016_88.

Full text

APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Beta agonists"

1

Villalobos, Ralph Elvi, and Aileen David-Wang. "Efficacy and safety of Long-acting Beta-agonists+Long-acting muscarinic antagonists vs Long-acting Beta-agonists+Inhaled corticosteroids in COPD: a meta-analysis." In ERS International Congress 2017 abstracts. European Respiratory Society, 2017. http://dx.doi.org/10.1183/1393003.congress-2017.pa938.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Assis, G., and C. Cruz. "Use of beta agonists in feeding stuff in Portugal: an overview." In Safe Pork 2015: Epidemiology and control of hazards in pork production chain. Iowa State University, Digital Press, 2015. http://dx.doi.org/10.31274/safepork-180809-335.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Lachowicz-Scroggins, Marrah E., Walter Finkbeiner, Jonathan Widdicombe, and Homer A. Boushey. "Effects Of Long-Acting Beta Agonists And Glucocorticoids On Rhinovirus Infection." In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a2762.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

Yang, N., G. K. Singhera, M. P. Pieper, D. R. Dorscheid, and D. D. Sin. "Anti-Inflammatory Effects of Long-Acting Beta Agonists on Bronchial Epithelium." In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a3756.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Datta, Jharna, Natalie Willingham, Jasmine Manouchehri, et al. "Abstract PS18-39: Estrogen receptor beta agonists for triple negative breast cancer." In Abstracts: 2020 San Antonio Breast Cancer Virtual Symposium; December 8-11, 2020; San Antonio, Texas. American Association for Cancer Research, 2021. http://dx.doi.org/10.1158/1538-7445.sabcs20-ps18-39.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Liggett, S. B., D. Kim, A. Tokmakova, M. Giulianotti, S. An, and W. Goddard. "Discovery and Characterization of the First Biased Beta-Agonist That Favors Gs-Coupling vs Beta-Arrestin Mediated Desensitization: A New Class of Structurally Distinct Beta-Agonists for Treating Obstructive Lung Diseases." In American Thoracic Society 2022 International Conference, May 13-18, 2022 - San Francisco, CA. American Thoracic Society, 2022. http://dx.doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a3249.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

Michele, Theresa M., Liang Zhao, and Chandrahas G. Sahajwalla. "Tachyphylaxis With Scheduled Use Of Short-Acting Beta-Agonists In Patients With Asthma." In American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a3955.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Worth, Heinrich, Carl-Peter Criée, Claus Vogelmeier, et al. "Overuse of short-acting beta-agonists (SABA) and risk factors among patients with asthma." In ERS International Congress 2020 abstracts. European Respiratory Society, 2020. http://dx.doi.org/10.1183/13993003.congress-2020.2633.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Sadatsafavi, Mohsen, Mark FitzGerald, Carlo Marra, and Larry Lynd. "Safety Of Long-Acting Beta Agonists (LABA) With Or Without Inhaled Corticosteroids In Asthma." In American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a6762.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

Radošević, Draginja, Kristina Stevanović, Vladimir Perović та Sanja Glišić. "Coumarins as promising PPARα agonists. Novel in silico insights". У 2nd International Conference on Chemo and Bioinformatics. Institute for Information Technologies, University of Kragujevac, 2023. http://dx.doi.org/10.46793/iccbi23.597r.

Full text

Abstract:

The occurrence of metabolic syndrome, which includes several chronic severe diseases such as cardiovascular disease, dyslipidemia, hypertension, stroke, and type 2 diabetes mellitus, is becoming a serious public health concern on a global scale. Peroxisome proliferator-activated receptor alpha (PPARα) is a ligand-activated transcription factor that are members of the nuclear hormone receptor superfamily. PPARα plays a crucial function in regulating the expression of genes involved in fatty acid beta-oxidation and glucose homeostasis, making it a potential drug target for treating metabolic syn

APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Beta agonists"

1

Beta-3 agonists in the management of detrusor overactivity. BJUI Knowledge, 2017. http://dx.doi.org/10.18591/bjuik.0051.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!